SavedAdd your journal

Journals / Journal of Clinical and Experimental Investigations / 2012 / Cilt: 3 - Sayı: 1

Hiperkalsemi ve kemik iliği infiltrasyonu ile başvuran bir overiyan malign melanom: Vaka sunumu ve literatür taraması

Ovarian malignant melanoma presenting with hypercalcemia and bone marrow infiltration: A case report and review of the literature

Ali İNAL
Abdurrahman IŞIKDOĞAN
Mehmet KÜÇÜKÖNER
Muhammet Ali KAPLAN
Zuhat URAKÇI
Pages
96–98
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

J Clin Exp Invest 2012; 3(1): 96-98

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Malignant melanoma originating from the ovary is a very rare condition.
📊
Key Findings & Data:Bone marrow involvement and hypercalcemia is observed at a very low rate in malignant melanoma cases (5-7 and 1.1-11.9%, respectively).
💡
Conclusion & Impact:J Clin Exp Invest 2012; 3(1): 96-98
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Malignant melanoma originating from the ovary is a very rare condition. Bone marrow involvement and hypercalcemia is observed at a very low rate in malignant melanoma cases (5-7 and 1.1-11.9%, respectively). In this paper, we present very rare condition as a 67-year-old female patient with malignant melanoma of ovary origin accompanied by bone marrow infiltration and hypercalcemia. J Clin Exp Invest 2012; 3(1): 96-98

Özet

Over kaynaklı malign melanom oldukça nadir bir durumdur. Kemik iliği tutulumu olması ve hiperkalsemi varlığı malign melanoma vakalarında çok düşük oranda gözlenmektedir (sırasıyla, % 5-7 and % 1.1-11.9). Bu yazıda biz de kemik iliği infiltrasyonu gösteren ve hiperkalsemisi bulunan oldukça nadir bir 67 yaşında kadın over kaynaklı malign melanoma vakasını sunduk.

🔖

Cite This Article

İNAL, A., IŞIKDOĞAN, A., KÜÇÜKÖNER, M., KAPLAN, M. A., URAKÇI, Z. (2022). Hiperkalsemi ve kemik iliği infiltrasyonu ile başvuran bir overiyan malign melanom: Vaka sunumu ve literatür taraması. Journal of Clinical and Experimental Investigations, Cilt: 3 - Sayı: 1, 96–98. https://ajindex.com/articles/561918

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996;34(6):839-47
  2. Gungor T, Altinkaya SO, Ozat M, Bayramoglu H, Mollamahmutoglu L. Primary malignant melanoma of the female genital tract. Taiwan J Obstet Gynecol 2009;48(2):169-75
  3. Irvin WP Jr, Legallo RL, Stoler MH, et al. Vulvar melanoma: a retrospective analysis and literature review. Gynecol Oncol 2001;83(3):457-65
  4. An JS, Wu LY, Li N, Li B, Yu GZ, Liu LY. Clinical analysis of 42 cases of primary malignant melanoma in female genital tract. Zhonghua Fu Chan Ke Za Zhi 2007;42(5):320-4
  5. Wang Y, Chang W, Pu D. Clinical analysis of 15 patients with primary malignant melanoma in the genital tract. Zhonghua Fu Chan Ke Za Zhi 1997;32(4):226-8
  6. Sugiyama VE, Chan JK, Kapp DS. Management of melanomas of the female genital tract. Curr Opin Oncol 2008;20(3):565-9
  7. Batsis JA, Barry MJ. Metastatic malignant melanoma presenting with hypercalcaemia and bone marrow involvement. J Eur Acad Dermatol Venereol 2006;20(3):432-4
  8. Savage RA, Lucas FV, Hoffman GC. Melanoma in marrow aspirates. Am J Clin Pathol 1983, 79(2):268-9
  9. Jain D, Singh T, Kumar N, Daga MK. Metastatic malignant melanoma in bone marrow with occult primary site - a case report with review of literature. Diagn Pathol 2007;2:38-41
  10. Gallivan MVE, Lokich JJ. Carcinocythemia (carcinoma cell leukemia). Cancer 1984; 53(8):1100-2
  11. Basu D, Bhade BA, Ghotekar LH, Mathew T, Dutta TK. Malignant melanoma metastatic to bone marrow. Indian J Pathol Microbiol 2002;45(1):107-9
  12. Schadendorf D, Dorn-Beineke A, Borelli S, Riethmuller G, Pantel K. Limitations of the immunocytochemical detection of isolated tumor cells in frozen samples of bone marrow obtained from melanoma patients. Exp Dermatol 2003;12(1):165-71
  13. Uesawa M, Sato K, Ozaki K, Nagai T, Muroi K, Ozawa K. Bone marrow metastasis of malignant melanoma. Intern Med 2006;45(2):341-6
  14. Wong KF. Metastatic melanoma. Br J Haematol 2006;134(4):554-8
  15. Lumachi F, Brunello A, Roma A, Basso U. Medical treatment of malignancy-associated hypercalcemia. Curr Med Chem 2008;15(3):415-21
  16. Burt ME, Brennan MF. Hypercalcemia and malignant melanoma. Case reports. Am J Surg 1977;137(5):790- 4
  17. Levy I, Feun L. Hypercalcemia and malignant melanoma. Am J Clin Oncol 1990;13(4):524-6
  18. Kageshita T, Matsui T, Hirai S, Fukuda Y, Ono T. Hypercalcemia in melanoma patients associated with i